Amy Lehman

7.3k citations

102 papers · 4.7k indexed · 2 hit papers · h-index 38

Impact in

Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 34
- Chronic Lymphocytic Leukemia Research 34
Pathology and Forensic Medicine 19
- Lymphoma Diagnosis and Treatment 8

Co-authors: John C. Byrd William E. Carson David Jarjoura E.A. de Weerd-Kastelein Susan Kirk‐Bell Malcolm C. Paterson D. Bootsma P.H.M. Lohman
Journals: Blood (24 papers)Clinical Cancer Research (6 papers)The Journal of Immunology (3 papers)Oncotarget (3 papers)American Journal of Clinical Pathology (3 papers)
Partner nations: United States Poland United Kingdom

In The Last Decade

Amy Lehman

101 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

Extracting insights from the shape of complex data using topology 2013 · 312 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Scientific Reports
1975 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Amy Lehman

Since Specialization

Citations

This map shows the geographic impact of Amy Lehman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Lehman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Lehman more than expected).

Fields of papers citing papers by Amy Lehman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Lehman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Lehman. The network helps show where Amy Lehman may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Lehman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Lehman Line = papers co-authored together Amy Lehman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pre‐diagnosis lipid levels and mortality after obesity‐related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort Cancer Medicine ·E Étienne, Ana Barac, Theodore M. Brasky, Aladdin H. Shadyab, Amy Lehman, Eric McLaughlin, Nazmus Saquib, Neil M. Iyengar, Robert A. Wild, Bette J. Caan, Pinkal Desai, Jennifer Beebe‐Dimmer, Cynthia A. Thomson, Michael S. Simon	2023	5
2	COPD and lung cancer incidence in the Women’s Health Initiative Observational Study: A brief report Lung Cancer ·Misako Nagasaka, Amy Lehman, Rowan T. Chlebowski, Brittany Haynes, Gloria Ho, Manali I. Patel, Lori C. Sakoda, Ann G. Schwartz, Michael S. Simon, Michele L. Coté	2020	9
3	Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia Journal of Hematology & Oncology ·Lindsey T. Brinton, Pu Zhang, Katie Williams, Singapuri Amisha, Shelley Orwick, 石维行, Thea Lien Espeland, Larry Beaver, 霍庆涛, Luis Ignacio Bonilla Reséndiz, Matthew Cannon, А. В. Сигай, Bonnie K. Harrington, Amy Lehman, John C. Byrd, Rosa Lapalombella, James S. Blachly	2020	37
4	Rural–Urban Residence and Stroke Risk and Severity in Postmenopausal Women: The Women's Health Initiative Women s Health Reports ·Shawnita Sealy–Jefferson, اکبر اعتباریان, Michele L. Coté, Amy Lehman, Eric A. Whitsel, Jason Booza, Michael S. Simon	2020	2
5	Fournier's Gangrene in Females: Presentation and Management at a Tertiary Center Urology ·Олег Терещенко, 신희라, X Spammer, FrancisK. Lee, Б. М. Аташ, Marilly Palettas, Amy Lehman, Yue Xu, Lawrence C. Jenkins, Nima Baradaran	2020	18
6	Medical dissolution therapy for the treatment of uric acid nephrolithiasis World Journal of Urology ·Thirakan Veingkam, رشا مجيد منديل الحاجم, Amy Lehman, Bodo E. Knudsen	2019	27
7	Rural–Urban Residence and Stage at Breast Cancer Diagnosis Among Postmenopausal Women: The Women's Health Initiative Journal of Women s Health ·Shawnita Sealy–Jefferson, اکبر اعتباریان, Michele L. Coté, Amy Lehman, Eric A. Whitsel, Zirui Wang, Jason Booza, Michael S. Simon	2018	14
8	Tubal Ligation and Risk of Endometrial Cancer International Journal of Gynecological Cancer ·Ira Winer, Amy Lehman, Jean Wactawski‐Wende, Randal D. Robinson, Michael S. Simon, Michele L. Coté	2016	4
9	Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study Menopause The Journal of The North American Menopause Society ·Shannon D. Sullivan, Amy Lehman, Fridtjof Thomas, Karen Johnson, Rebecca D. Jackson, Jean Wactawski‐Wende, Marcia Ko, Zhao Chen, J. David Curb, Barbara V. Howard	2015	30
10	Statins and breast cancer stage and mortality in the Women’s Health Initiative Cancer Causes & Control ·Pinkal Desai, Amy Lehman, Rowan T. Chlebowski, Marilyn L. Kwan, Ahmad Mokhtar Ahmad, JoAnn E. Manson, Sayeh Lavasani, Guilherme Conceição de Oliveira, Gloria E. Sarto, Meryl S. LeBoff, Jane A. Cauley, Michele L. Coté, Jennifer Beebe‐Dimmer, Domenico Chiarella, Michael S. Simon	2015	58
11	The Proteasome Inhibitor Carfilzomib Functions Independently of p53 to Induce Cytotoxicity and an Atypical NF-κB Response in Chronic Lymphocytic Leukemia Cells Clinical Cancer Research ·Sneha Gupta, Erin Hertlein, Yanhui Lu, Ellen J. Sass, Rosa Lapalombella, Timothy L. Chen, Melanie E. Davis, Jennifer A. Woyach, Amy Lehman, David Jarjoura, John C. Byrd, David Lucas	2013	31
12	DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas Clinical Cancer Research ·Kazuo Okemoto, Kazue Kasai, О. П. Шевченко, Amy Haseley, V. V. Zadymov, Chelsea Bolyard, Xiaokui Mo, Allison Wehr, Amy Lehman, Soledad Fernández, Balveen Kaur, E. Antonio Chiocca	2013	23
13	IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production The Journal of Immunology ·Alena Cristina Jaime‐Ramirez, Bethany L. Mundy-Bosse, Б. Н. Маврин, Natalie Jones, Julie M. Roda, Aruna Mani, Robin Parihar, Volodymyr Karpa, Tracey L. Papenfuss, Krista LaPerle, MM Nowell, Amy Lehman, Abhik Ray Chaudhury, David Jarjoura, Richard W. Burry, William E. Carson	2011	81
14	Intrauterine lidocaine infusion for pain management during outpatient transcervical tubal sterilization: a randomized controlled trial Contraception ·木曽田恵子, Jeffrey T. Jensen, Mark Nichols, Amy Lehman, Paula Bednarek, Alison Edelman	2011	11
15	Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells The AAPS Journal ·Sneha Gupta, Ellen J. Sass, Melanie E. Davis, Ryan B. Edwards, Gerard Lozanski, Nyla A. Heerema, Amy Lehman, Xiaoli Zhang, David Jarjoura, John C. Byrd, Li Pan, Kenneth K. Chan, A. Douglas Kinghorn, Mitch A. Phelps, Michael R. Grever, David Lucas	2011	63
16	ω-3 Fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition American Journal of Clinical Nutrition ·Xuhui Lee, S Douglas Prasier, Rachel M. Cole, Hassanat R. Abdel-Aziz, Jason C. Hsu, Yan Li, Amy Lehman, Martha A. Belury, Steven K. Clinton	2010	78
17	Epidemiology and Risk Factors for Thromboembolic Complications of Childhood Nephrotic Syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) Study The Journal of Pediatrics ·Bryce A. Kerlin, Neal B. Blatt, Beng Fuh, Shuang Zhao, Amy Lehman, Carol A. Blanchong, John D. Mahan, William E. Smoyer	2009	91
18	Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia Journal of Clinical Oncology ·Leslie A. Andritsos, Amy J. Johnson, Gerard Lozanski, William Blum, Cheryl Kefauver, Farrukh T. Awan, Lisa L. Smith, Rosa Lapalombella, Sarah May, Chelsey A. Raymond, Da-Sheng Wang, Robert Knight, Amy S. Ruppert, Amy Lehman, David Jarjoura, Ching-Shih Chen, John C. Byrd	2008	117
19	A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma Annals of Surgical Oncology ·Kimberly A. Varker, D. Kovalskyi, Cheryl Kefauver, 中西徹や, Amy Lehman, Donn C. Young, Haifeng Wu, Gregory B. Lesinski, Kari Kendra, Helen X. Chen, Michael J. Walker, William E. Carson	2007	118
20	Chronic Stress and Susceptibility to Skin Cancer JNCI Journal of the National Cancer Institute ·Edward J. Zaleski, Tatiana M. Oberyszyn, Christine Daugherty, Donna F. Kusewitt, Susie Jones, Scott D. Jewell, William B. Malarkey, Amy Lehman, Stanley Lemeshow, Firdaus S. Dhabhar	2005	157

About Amy Lehman

Amy Lehman is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Immunology and Hematology, having authored 102 papers that have together received 4.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (34 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Immune Cell Function and Interaction (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), T-cell and B-cell Immunology (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Genetics (919 citations), Pathology and Forensic Medicine (858 citations), Immunology (925 citations), Oncology (1.2k citations) and Hematology (445 citations). Amy Lehman has collaborated with scholars based in United States, Poland and United Kingdom. Frequent co-authors include John C. Byrd, William E. Carson, David Jarjoura, E.A. de Weerd-Kastelein, Susan Kirk‐Bell, Malcolm C. Paterson, D. Bootsma, P.H.M. Lohman, C. F. Arlett and Susheela Tridandapani. Their work appears in journals such as Blood, Clinical Cancer Research, The Journal of Immunology, Oncotarget and American Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact